Medical Technologies

Require or Encourage? IGWG text on open access

Re: The WHO IGWG Text on Access to Publicly Funded Research Provision, from “Requirement” to “Encouragement”?

One of the outcomes of the Nov. 5-10, 2007 second session of the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG2) is a provision on access to government funded research.

Andrew Pollack on Gilead’s $130 pill for pulmonary arterial hypertension

This is Andrew Pollack’s recent story on Gilead’s new $130 per pill (use daily) for pulmonary arterial hypertension. The price of this drug, which is a once daily pill, is roughly the average per capita income in the United States, leaving nothing else for food, housing, clothing or having a beer at the local bar.

The Development Agenda: Crunch time at WIPO

The future of the WIPO Development Agenda enters a crucial phase this week as WIPO Member States meet at the fourth session of the Provisional Committee on Proposals Related to a WIPO Development Agenda (PCDA).

Syndicate content